Department of Emergency Medicine, Singapore General Hospital, Singapore.
Ann Acad Med Singap. 2020 Mar;49(3):127-136.
The use of targeted temperature management (TTM) is increasing although adoption is still variable. We describe our 6-year experience and compare the mortality and neurological outcomes of out-of-hospital cardiac arrest (OHCA) patients with and without the use of TTM in a multiethnic Asian population.
We performed a retrospective observational study at a tertiary academic medical centre. OHCA survivors admitted to our hospital between April 2010‒December 2016 were included. Outcomes of interest were 30-day mortality postresuscitation, Cerebral Performance Category (CPC) and Overall Performance Category (OPC) scores.
A total of 121 of 261 patients (46.3%) underwent TTM. TTM patients were younger (TTM 60.0 years old vs no TTM 63.7 years old, = 0.047). There was no difference in the initial arrest rhythm of shockable origin between the 2 groups ( = 0.289). There was suggestion of lower 30-day mortality (TTM 24.3% vs no TTM 31.4%, = 0.214), higher and good CPC/OPC scores (TTM 19.0% vs no TTM 15.7%, = 0.514) with TTM although this did not reach statistical significance. On multivariable logistic regression analysis, TTM was not associated with 30-day mortality ( = 0.07). However, older age, initial non-shockable rhythm and increased duration from arrest to return of spontaneous circulation were associated with increased mortality. Malay ethnicity was associated with a poorer CPC/ OPC score.
Adoption and outcomes of TTM postresuscitation is variable and there is still a need to optimise management of the identified predictors of survival and good neurological outcomes while TTM is being used.
尽管靶向体温管理(TTM)的应用仍存在差异,但使用量正在增加。我们描述了我们在一个多民族亚洲人群中的 6 年经验,并比较了使用和不使用 TTM 的院外心脏骤停(OHCA)患者的死亡率和神经功能结局。
我们在一家三级学术医疗中心进行了回顾性观察研究。纳入 2010 年 4 月至 2016 年 12 月期间我院收治的 OHCA 幸存者。主要观察指标为复苏后 30 天死亡率、脑功能分类(CPC)和总体功能分类(OPC)评分。
共有 261 例患者中的 121 例(46.3%)接受了 TTM。TTM 患者年龄更小(TTM 60.0 岁 vs 非 TTM 63.7 岁, = 0.047)。两组初始骤停节律为可除颤起源无差异( = 0.289)。TTM 组 30 天死亡率较低(TTM 24.3% vs 非 TTM 31.4%, = 0.214),CPC/OPC 评分较高且良好(TTM 19.0% vs 非 TTM 15.7%, = 0.514),尽管这并未达到统计学意义。多变量逻辑回归分析显示,TTM 与 30 天死亡率无关( = 0.07)。然而,年龄较大、初始非可除颤节律以及从骤停到自主循环恢复的时间延长与死亡率增加相关。马来族裔与较差的 CPC/OPC 评分相关。
复苏后 TTM 的应用和结局存在差异,在使用 TTM 的同时,仍需要优化对生存和良好神经功能结局的预测因素的管理。